FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40214111000001108: Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2079221000001119 Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2079241000001112 Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has AMP Tukysa 150mg tablets (Seagen U.K. Ltd) true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Is a Tucatinib 150mg tablets 84 tablet true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has specific active ingredient Tucatinib true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tukysa 150mg tablets (Seagen U.K. Ltd) 84 tablet 21 x 4 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start